PTPRC and systemic lupus erythematosus: 9G4 antibodies represent 10–45% of the total serum IgG in patients with active disease42–44,58, which account for the vast majority of anti-B cell CD45 antibodies and a significant fraction of anti-dsDNA in SLE.